Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of postpartum hemorrhage
3.2.1.2 Increasing initiatives by government and various organizations
3.2.1.3 Rising publicly funded family planning services
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of awareness among rural population
3.2.2.2 Adverse effects associated with use of contraceptive drugs and devices
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Postpartum hemorrhage treatment
5.3 Pregnancy abortion
Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Hospital pharmacies
6.3 Retail pharmacies
6.4 Online pharmacies
Chapter 7 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East and Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Advancion Corporation
8.2 Amneal Pharmaceuticals, Inc.
8.3 Apionex Pharma Pvt Ltd.
8.4 Biosynth Limited
8.5 Bio-Techne Corporation
8.6 BioSpectra Inc.
8.7 Dr. Reddy's Laboratories Ltd.
8.8 Merck & Co., Inc.
8.9 Monvi Laboratories Private Limited
8.10 Manus Aktteva Biopharma Llp
8.11 Pfizer Inc.
8.12 Ryvis Pharma Private Limited
8.13 SimSon Pharma Limited
8.14 Taj Pharmaceuticals Limited
8.15 The International Chemical Secretariat
8.16 Universal Biosensors, Inc.
8.17 Willis Towers Watson Public Limited Company
8.18 Woodward, Inc.
